Indeed, this idea has demonstrated effectiveness in the context of colony stimulating factor 1 receptor (CSF1R) inhibition, where GAMs can become “re-educated” within the glioma microenvironment to adopt an anti-tumorigenic phenotype [58]. The gene discussed is CSF1R; the disease is glioma.